GET LIVE DEMO
BB: 2,25x52,75 Size: ≤5 Type: Nonneoplastic
MAGENTIQ EYE

Gastroenterology powered by AI

scroll

A game changer in CRC prevention

Research¹ shows that for every per cent increase in adenoma detection, there is a 3 per cent decrease in the occurrence of Colorectal Cancer (CRC), the third most prevalent cancer worldwide, and one of the deadliest.
In this reality, it is no surprise that colonoscopy aided by Artificial Intelligence (AI) and Machine Learning (ML) technologies, which power diagnostic capabilities, and significantly improve clinical decision-making, has become the new standard in high-performing gastroenterology clinics.

The Magentiq Eye difference

Dedicated to the use of advanced technologies to transform procedure performance in the gastroenterology field,
we offer an incomparable combination of efficiency and economic value.

Product

performance

Unique

features

Guaranteed

software updates

Fast ROI

business model

Read more

A new benchmark for AI aided colonoscopy

With more than 65,000,000 frames processed, analyzed and tagged over the course of seven years, and validation from a comprehensive study covering more than 950 patients in 10 centers across the globe, our outstanding detection and analysis capabilities are setting new standards.

0 % apc
Adenoma Per Colonoscopy
0 % amr
Adenoma Miss Rate
0 % adr
Adenoma Detection Rate
0 % ssapc
Sessile Serrated APC
View study

Validated by
leading hospitals & clinics

What they say about us

I use Magentiq as a real-time adjunct during colonoscopy. Compared with other AI platforms, it’s more precise with subtle, low-contrast lesions and produces fewer distracting false positives, making it the most clinically useful second reader I’ve used.

Shakeel Ahmed, M.D., MRCP, FACP, FACG, FASGE.
Professor of Clinical Medicine, Western Atlantic University School of Medicine. Interventional Gastroenterology, Transplant Hepatology and Nutrition, Obesity and Aesthetic Medicine. Member, Forbes Technology Council. Publisher, Surgery Business Magazine.

MAGENTIQ-COLO™ is easy to use and adds to quality in the procedure room. By using such AI products, we found in a recent study that less polyps were missed, the ADR increased, and more lives are potentially saved.

Prof. Peter Siersema, MD, Ph.D
Senior gastroenterologist & researcher, Erasmus MC, Rotterdam, The Netherlands & Editor-in-Chief, Endoscopy Journal

I’m very pleased with the MAGENTIQ-COLO™ product. The system fits extremely well to the gastroenterology clinics and assists the doctors during colonoscopy. Thanks to the AI detection more polyps can be detected.

Univ.-Prof. Dr. MD Helmut Neumann
Internationally recognized internist & gastroenterologist

MAGENTIQ EYE’s clinical study which Hadassah took part in, is (to the best of my knowledge), the largest randomized, blinded, international, multi center control trial ever done on AI and polyp detection. It sets new standards of colonoscopy performance, with a 37% relative increase in APC, a 26% relative increase in ADR, and a 48% relative decrease in AMR. 

Dr. Harold Jacob, MD
Director of Gastrointestinal Endoscopy at Hadassah University Medical Center

Public systems investing in mass screening are concerned with the quality of colonoscopy, but with MAGENTIQ COLO they can guarantee that the “worst” quality colonoscopy achieves the same level of accuracy as the best. This is not only life saving but also reduces the financial burden of transitioning into mass screening from about 10 years,  to between 2-6. This is a game changer.

Jen Kees Dunning
Healthcare Consultant, Netherlands

Magentiq Eye’s AI product is very helpful in endoscopy and their service is excellent. The cooperation with Magentiq Eye during the pivotal clinical study was great.

Dr. Marc Landsman, MD
Senior Internist & Gastroenterologist and Fellowship Program Director, MetroHealth Medical Center, Ohio
BB: 2,25x52,75 Size: Type:

Combined GI Procedures Are Becoming Routine – AI Can Help Address the Gap in Upper GI Quality Standards

Dror Zur on how why upper GI quality has lagged behind despite growing procedure volumes, and how AI can help bridge this gap.

Go to article

Live demo request

Demo Request

What’s new

See all
AI Can Help Address the Gap in Upper GI Quality Standards? by Dror Zur, Magentiq Eye
Combined upper and lower GI endoscopy is becoming standard practice across many US healthcare settings, but the quality infrastructure for…
MAGENTIQ EYE Releases New MAGENTIQ-COLO(TM) Versions Expanding User Experience and AI-Based Quality Metrics in Colonoscopy by Magentiq Eye Marketing,
New FDA-cleared version with tool detection and CE-marked version with additional quality (CAQ) features further strengthen MAGENTIQ-COLO™'s AI platform
CAD Improves Multiple Colonoscopy Metrics in International Trial by Caroline Helwick, Gastroenterology & Endoscopy News
A multinational trial and subtrial have added to the growing body of evidence supporting the inclusion of artificial intelligence in…
HOYA Group Company, PENTAX of America, Inc. and MAGENTIQ EYE Ltd. Announce their Intention to Form a Distribution Partnership for the U.S Market by Hoya Group / Pentax Medical / Magentiq Eye, press release
AI-Aided Colonoscopy Technology: Dror Zur from Magentiq Eye in a Dialogue Exchange with PharmaShots by Saurabh Chaubey, PharmaShots
Shots:  * Dror Zur, CEO and Founder of Magentiq Eye in a stimulating conversation with PharmaShots talks about the Lancet Digital Health Study journal…
The Incrementalist: AI Revolution in Gastroenterology with Dror Zur, CEO at Magentiq Eye by Dr. Nick van Terheyden, Healthcare NOW Radio Podcast Network
Host Dr. Nick van Terheyden aka Dr. Nick, discusses AI Revolution in Gastroenterology with Dror Zur, CEO at Magentiq Eye.…